Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CYTR NASDAQ:ETHZ NASDAQ:FTXH NASDAQ:PCLA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCYTRLadRx$0.09$0.05▼$0.86$4.14MN/A99,706 shs4,000 shsETHZFlag Ship Acquisition$2.55+5.8%$0.00$0.66▼$17.75$14.55M0.3715.13 million shs14.68 million shsFTXHFirst Trust Nasdaq Pharmaceuticals ETF$28.09-1.4%$27.06$23.28▼$29.69$15.40M0.76,953 shs107 shsPCLAPicoCELA$0.54+8.8%$0.78$0.37▼$9.80$13.45MN/A206,696 shs224,357 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCYTRLadRx0.00%0.00%0.00%0.00%0.00%ETHZFlag Ship Acquisition0.00%+10.39%+254,999,900.00%+254,999,900.00%+254,999,900.00%FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.00%-0.48%+2.71%+7.62%-2.80%PCLAPicoCELA0.00%+22.97%-0.92%-54.02%+53,799,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCYTRLadRx$0.09$0.05▼$0.86$4.14MN/A99,706 shs4,000 shsETHZFlag Ship Acquisition$2.55+5.8%$0.00$0.66▼$17.75$14.55M0.3715.13 million shs14.68 million shsFTXHFirst Trust Nasdaq Pharmaceuticals ETF$28.09-1.4%$27.06$23.28▼$29.69$15.40M0.76,953 shs107 shsPCLAPicoCELA$0.54+8.8%$0.78$0.37▼$9.80$13.45MN/A206,696 shs224,357 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCYTRLadRx0.00%0.00%0.00%0.00%0.00%ETHZFlag Ship Acquisition0.00%+10.39%+254,999,900.00%+254,999,900.00%+254,999,900.00%FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.00%-0.48%+2.71%+7.62%-2.80%PCLAPicoCELA0.00%+22.97%-0.92%-54.02%+53,799,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCYTRLadRx 0.00N/AN/AN/AETHZFlag Ship Acquisition 0.00N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF 2.52Moderate Buy$28.09N/APCLAPicoCELA 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCYTRLadRxN/AN/AN/AN/AN/AN/AETHZFlag Ship AcquisitionN/AN/AN/AN/A$2.91 per shareN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/APCLAPicoCELA$5.22M2.81N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCYTRLadRxN/AN/A0.00N/AN/AN/AN/AN/AN/AETHZFlag Ship Acquisition-$6.17M-$15.07N/A∞N/AN/A-141.25%-80.77%N/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A14.51∞N/AN/AN/AN/AN/APCLAPicoCELA-$3.21MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCYTRLadRxN/AN/AN/AN/AN/AETHZFlag Ship AcquisitionN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.441.57%N/AN/AN/APCLAPicoCELAN/AN/AN/AN/AN/ALatest CYTR, ETHZ, FTXH, and PCLA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/25/2025FTXHFirst Trust Nasdaq Pharmaceuticals ETFQuarterly$0.08921.39%6/26/20256/26/20256/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCYTRLadRxN/AN/AN/AETHZFlag Ship AcquisitionN/A0.580.58FTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/APCLAPicoCELAN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCYTRLadRxN/AETHZFlag Ship Acquisition4.07%FTXHFirst Trust Nasdaq Pharmaceuticals ETFN/APCLAPicoCELAN/AInsider OwnershipCompanyInsider OwnershipCYTRLadRxN/AETHZFlag Ship Acquisition38.20%FTXHFirst Trust Nasdaq Pharmaceuticals ETFN/APCLAPicoCELAN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCYTRLadRxN/A45.04 millionN/ANot OptionableETHZFlag Ship Acquisition76.04 million3.73 millionN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000550,000N/AOptionablePCLAPicoCELA5327.22 millionN/AN/ACYTR, ETHZ, FTXH, and PCLA HeadlinesRecent News About These CompaniesPicoCELA (NASDAQ:PCLA) Trading Up 1.1% - Here's What HappenedSeptember 12 at 4:15 AM | americanbankingnews.comPicoCELA Inc. Issues Restricted Common Shares to MCC and You PlanningAugust 30, 2025 | tmcnet.comPicoCELA Strengthens Financial Position with New Share IssuanceAugust 29, 2025 | tipranks.comPicoCELA Inc. Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyAugust 29, 2025 | prnewswire.comPicoCELA Inc. Issues Restricted Common Shares to Nikken Lease Kogyo Co. Ltd.May 1, 2025 | prnewswire.comPicoCELA Inc. Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 24, 2025 | prnewswire.comPicoCELA Inc. American Depositary Shares (PCLA) Institutional HoldingsMarch 30, 2025 | nasdaq.comPicoCELA files to sell 6.1M American Depositary SharesMarch 13, 2025 | markets.businessinsider.comPicocela Inc ADR (PCLA)February 22, 2025 | investing.comPicoCELA Reports Higher Revenue and Lower Net Loss for the Fiscal Year Ended September 30, 2024February 18, 2025 | prnewswire.comPicoCELA Inc ADR PCLAFebruary 11, 2025 | morningstar.comMPicocela Inc trading resumesFebruary 6, 2025 | msn.comPicocela Inc trading halted, volatility trading pauseFebruary 6, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCYTR, ETHZ, FTXH, and PCLA Company DescriptionsLadRx NASDAQ:CYTRLadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.Flag Ship Acquisition NASDAQ:ETHZ$2.55 +0.14 (+5.81%) As of 09/12/2025 04:00 PM Eastern1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH$28.09 -0.40 (-1.40%) Closing price 09/12/2025 03:50 PM EasternExtended Trading$28.09 0.00 (0.00%) As of 09/12/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.PicoCELA NASDAQ:PCLA$0.54 +0.04 (+8.82%) As of 09/12/2025 04:00 PM EasternPicoCELA, Inc. engages in the manufacturing, installation, and services for enterprise wireless mesh solutions. It also offers wireless multi-hop relay devices. The company was founded by Hiroshi Furukawa on August 8, 2008 and is headquartered in Tokyo, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
